📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle. (2016)

First Author: Sakellariou GK

Attributed to: CIMA: The Centre for Integrated Research into Musculoskeletal Ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.201600450r

PubMed Identifier: 27550965

Publication URI: http://europepmc.org/abstract/MED/27550965

Type: Journal Article/Review

Volume: 30

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 11

ISSN: 0892-6638